Linked Life Data

7757362

Source:http://linkedlifedata.com/resource/pubmed/id/7757362

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1995-6-26
pubmed:abstractText
The immunological efficacy of serogroup B meningococcal protein-polysaccharide vaccine was studied in newly developed immune bacteriolysis test. Serogroup B meningococcus strains had different sensitivities to the bactericidal effects of immune sera. A single injection of the vaccine caused an induction of bactericidal antibodies to meningococcus vaccinal strain. Three weeks after vaccination 77.7% of the vaccines developed an appreciable increase of the titers of bactericidal antibodies to the homologous strain of meningococcus. The concentration of bactericidal antibodies to strain 2394 differing from the homologous strain by its serotype did not increase. In the controls no changes in the titers of bactericidal antibodies to both strains of meningococcus were observed, the level of antibodies being the same as that before vaccination in the group of subjects immunized with B vaccine; this proves the specificity of the immunizing effect to serogroup B meningococcus vaccinal strain (No 125).
pubmed:language
rus
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0869-2084
pubmed:author
pubmed:issnType
Print
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
26-9
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed:articleTitle
[Immune bacteriolysis reaction in the assessment of immunological effectiveness of serogroup B meningococcal vaccine].
pubmed:publicationType
Journal Article, Comparative Study, English Abstract